Archive: September2023

The outlook for the UK pharmaceutical, life sciences, biotech and laboratory sectors (referred to in this article as pharmaceutical and laboratories) is rapidly changing, with many challenging factors persisting and evolving. There is a feeling of a post-COVID adjustment in the industry following the UK focus on vaccine development and production scale-up of the last Continue reading